Brand name
Symdeko, the original
We didn’t find a savings card or cash price from Symdeko’s maker. Ask the pharmacy for Symdeko’s cash price. With insurance, ask what your plan charges.
Generic name: tezacaftor and ivacaftor
Used for: Cystic fibrosis (CF) with certain gene mutations
Ask for the cash price
Symdeko
We didn’t find one.
Symdeko, the original
We didn’t find a savings card or cash price from Symdeko’s maker. Ask the pharmacy for Symdeko’s cash price. With insurance, ask what your plan charges.
There isn’t one.
We didn’t find one.
SYMDEKO is a combination of tezacaftor and ivacaftor, indicated for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who are homozygous for the F508del mutation or who have at least one mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to tezacaftor/ivacaftor based on in vitro data and/or clinical evidence.
If the patient's genotype is unknown, an FDA-cleared CF mutation test should be used to detect the presence of a CFTR mutation followed by verification with bi-directional sequencing when recommended by the mutation test instructions for use.
Source: the FDA label for Symdeko (Vertex Pharmaceuticals Incorporated), August 21, 2026. Full label on DailyMed
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/symdeko/